文献速递临床试验与 GCP

多点起搏与常规ICD在窄QRS波心衰患者中的比较(MPP Narrow QRS试验):一项先导性随机对照试验的研究方案

Multipoint Pacing versus conventional ICD in Patients with a Narrow QRS complex (MPP Narrow QRS trial): study protocol for a pilot randomized controlled trial.
PubMed 文献 · Trials · 2016-12-03

MPP Narrow QRS试验是一项前瞻性、随机、多中心、对照可行性研究,计划纳入50例有标准ICD适应证的窄QRS波(100-130 ms)心衰患者,按1:1随机分为多点起搏(MPP)组或标准ICD组,仅纳入低剂量多巴酚丁胺负荷超声心动图证实有收缩储备者。主要终点为12个月时左室收缩末期容积(LVESV)较基线降低>15%的患者百分比。

要点

  • 研究纳入窄QRS波(100-130 ms)且低剂量多巴酚丁胺负荷超声有收缩储备的心衰患者。
  • 50例患者按1:1随机接受MPP或标准ICD,随访至12个月。
  • 主要终点为12个月时LVESV较基线降低>15%的患者比例。

核心结论

  • 该可行性研究将判断在窄QRS波(100-130 ms)心衰患者中,与标准ICD相比,MPP能否改善逆转重构。

研究设计与样本

  • 前瞻性、随机、多中心、对照可行性研究,计划纳入50例有标准ICD适应证的窄QRS波(100-130 ms)心衰患者,按1:1随机分为MPP组或标准ICD组。
  • 所有患者接受低剂量多巴酚丁胺负荷超声心动图检查,仅有收缩储备者被纳入并随机。

关键数值与推荐

  • 主要终点为12个月时左室收缩末期容积(LVESV)较基线降低>15%的患者百分比。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Despite an intensive search for predictors of the response to cardiac resynchronization therapy (CRT), the QRS duration remains the simplest and most robust predictor of a positive response. QRS duration of ≥ 130 ms is considered to be a prerequisite for CRT; however, some studies have shown that CRT may also be effective in heart failure (HF) patients with a narrow QRS (<130 ms). Since CRT can now be performed by pacing the left ventricle from multiple vectors via a single quadripolar lead, it is possible that multipoint pacing (MPP) might be effective in HF patients with a narrow QRS. This article reports the design of the MPP Narrow QRS trial, a prospective, randomized, multicenter, controlled feasibility study to investigate the efficacy of MPP using two LV pacing vectors in patients with a narrow QRS complex (100-130 ms). METHODS: Fifty patients with a standard ICD indication will be enrolled and randomized (1:1) to either an MPP group or a Standard ICD group. All patients will undergo a low-dose dobutamine stress echo test and only those with contractile reserve will be included in the study and randomized. The primary endpoint will be the percentage of patients in each group that have reverse remodeling at 12 months, defined as a reduction in left ventricular end-systolic volume (LVESV) of >15% from the baseline. DISCUSSION: This feasibility study will determine whether MPP improves reverse remodeling, as compared with standard ICD, in HF patients who have a narrow QRS complex (100-130 ms). TRIAL REGISTRATION: ClinicalTrials.gov, NCT02402816 . Registered on 25 March 2015.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Gasparini M, Galimberti P, Bragato R, et al. Multipoint Pacing versus conventional ICD in Patients with a Narrow QRS complex (MPP Narrow QRS trial): study protocol for a pilot randomized controlled trial. Trials. 2016. PMID: 27927248

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。